[1]
|
中华医学会肝病学分会脂肪肝和酒精性肝病学组, 中国医师协会脂肪性肝病专家委员会. 非酒精性脂肪性肝病防治指南(2018更新版) [J]. 中华肝脏病杂志, 2018, 26(3): 195-203.
https://doi.org/10.3760/cma.j.issn.1007-3418.2010.03.002
|
[2]
|
Manne, V., Handa, P. and Kowdley, K.V. (2018) Pathophysiology of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis. Clinics in Liver Disease, 22, 23-37.
|
[3]
|
姜煜资, 聂红明, 汪蓉. 非酒精性脂肪性肝病的发病机制[J]. 临床肝胆病杂志, 2019, 35(11): 2588-2591.
https://doi.org/10.3969/j.issn.1001-5256.2019.11.044
|
[4]
|
Sookoian, S. and Pirola, C.J. (2017) Genetic Predisposition in Nonalcoholic Fatty Liver Disease. Clinical and Molecular Hepatology, 23, 1-12. https://doi.org/10.3350/cmh.2016.0109
|
[5]
|
Younossi, Z., Anstee, Q.M., Marietti, M., et al. (2018) Global Burden of NAFLD and NASH: Trends, Predictions, Risk Factors and Prevention. Nature Reviews Gastroenterology & Hepatology, 15, 11-20.
https://doi.org/10.1038/nrgastro.2017.109
|
[6]
|
Younossi, Z., Koenig, A.B., Abdelatif, D., et al. (2016) Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes. Hepatology, 64, 73-84.
|
[7]
|
Fan, J.G. (2013) Epidemiology of Alcoholic and Nonalcoholic Fatty Liver Disease in China: Fatty Liver in China. Journal of Gastroenterology and Hepatology, 28, 11-17.
|
[8]
|
Pais, R., Barritt, A.S., Calmus, Y., et al. (2016) NAFLD and Liver Transplantation: Current Burden and Expected Challenges. Journal of Hepatology, 65, 1245-1257.
|
[9]
|
Younossi, Z., Tacke, F., Arrese, M., et al. (2019) Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Hepatology. Hepatology, 69, 2672-2682.
|
[10]
|
Feldstein, A.E., Wieckowska, A., Lopez, A.R., et al. (2009) Cytokeratin-18 Fragment Levels as Noninvasive Biomarkers for Nonalcoholic Steatohepatitis: A Multicenter Validation Study. Hepatology, 50, 1072-1078.
|
[11]
|
Vilar-Gomez, E. and Chalasani, N. (2018) Non-Invasive Assessment of Non-Alcoholic Fatty Liver Disease: Clinical Prediction Rules and Blood-Based Biomarkers. Journal of Hepatology, 68, 305-315.
https://doi.org/10.1016/j.jhep.2017.11.013
|
[12]
|
Palekar, N.A., Naus, R., Larson, S.P., et al. (2006) Clinical Model for Distinguishing Nonalcoholic Steatohepatitis from Simple Steatosis in Patients with Nonalcoholic Fatty Liver Disease. Liver International, 26, 151-156.
|
[13]
|
Gholam, P.M., Flancbaum, L., Machan, J.T., et al. (2007) Nonalcoholic Fatty Liver Disease in Severely Obese Subjects. American Journal of Gastroenterology, 102, 399-408. https://doi.org/10.1111/j.1572-0241.2006.01041.x
|
[14]
|
Feldstein, A.E., Lopez, R., Tamimi, T.A.R., et al. (2010) Mass Spectrometric Profiling of Oxidized Lipid Products in Human Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. Journal of Lipid Research, 51, 3046-3054.
https://doi.org/10.1194/jlr.M007096
|
[15]
|
Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD), Sumida, Y., Yoneda, M., et al. (2011) A Simple Clinical Scoring System Using Ferritin, Fasting Insulin, and Type IV Collagen 7S for Predicting Steatohepatitis in Nonalcoholic Fatty Liver Disease. Journal of Gastroenterology, 46, 257-268.
https://doi.org/10.1007/s00535-010-0305-6
|
[16]
|
Newsome, P.N., Sasso, M., Deeks, J.J., et al. (2020) FibroScan-AST (FAST) Score for the Non-Invasive Identification of Patients with Non-Alcoholic Steatohepatitis with Significant Activity and Fibrosis: A Prospective Derivation and Global Validation Study. The Lancet Gastroenterology & Hepatology, 5, 362-373.
https://doi.org/10.1016/S2468-1253(19)30383-8
|
[17]
|
Harrison, S.A., Ratziu, V., Boursier, J., et al. (2020) A Blood-Based Biomarker Panel (NIS4) for Non-Invasive Diagnosis of Non-Alcoholic Steatohepatitis and Liver Fibrosis: a Prospective Derivation and Global Validation Study. The Lancet Gastroenterology & Hepatology, 5, 970-985. https://doi.org/10.1016/S2468-1253(20)30252-1
|
[18]
|
Hernaez, R., Lazo, M., Bonekamp, S., et al. (2011) Diagnostic Accuracy and Reliability of Ultrasonography for the Detection of Fatty Liver: A Meta-Analysis. Hepatology, 54, 1082-1090.
|
[19]
|
Dietrich, C., Bamber, J., Berzigotti, A., et al. (2017) EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Short Version). Ultraschall in der Medizin, 38, 377-394.
https://doi.org/10.1055/s-0043-103955
|
[20]
|
Friedrich-Rust, M., Poynard, T. and Castera, L. (2016) Critical Comparison of Elastography Methods to Assess Chronic Liver Disease. Nature Reviews Gastroenterology & Hepatology, 13, 402-411.
https://doi.org/10.1038/nrgastro.2016.86
|
[21]
|
Ferraioli, G., Wong, V.W.S., Castera, L., et al. (2018) Liver Ultrasound Elastography: An Update to the World Federation for Ultrasound in Medicine and Biology Guidelines and Recommendations. Ultrasound in Medicine & Biology, 44, 2419-2440. https://doi.org/10.1016/j.ultrasmedbio.2018.07.008
|
[22]
|
Eddowes, P.J., Sasso, M., Allison, M., et al. (2019) Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology, 156, 1717-1730. https://doi.org/10.1053/j.gastro.2019.01.042
|
[23]
|
Khalifa, A. and Rockey, D.C. (2020) The Utility of Liver Biopsy in 2020. Current Opinion in Gastroenterology, 36, 184-191. https://doi.org/10.1097/MOG.0000000000000621
|
[24]
|
Boyd, A., Cain, O., Chauhan, A., et al. (2020) Medical Liver Biopsy: Background, Indications, Procedure and Histopathology. Frontline Gastroenterology, 11, 40-47. https://doi.org/10.1136/flgastro-2018-101139
|
[25]
|
Segovia-Miranda, F., Morales-Navarrete, H., Kücken, M., et al. (2019) Three-Dimensional Spatially Resolved Geometrical and Functional Models of Human Liver Tissue Reveal New Aspects of NAFLD Progression. Nature Medicine, 25, 1885-1893. https://doi.org/10.1038/s41591-019-0660-7
|